CGON
CG Oncology, Inc.
72.61
-0.03 (-0.04%)
52w low 37.01
80.97 high
81.0% of range
Financial Analysis
| (USD) | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Cash & Equivalents | -- | 88.14M | 8.27M | 257.07M | 32.49M | |
| Receivables | -- | -- | -- | 0.00 | 688.00K | |
| Inventory | -- | -- | -- | 0.00 | 1.56M | |
| Current Assets | -- | 147.21M | 194.12M | 754.21M | 759.48M | |
| Net PP&E | -- | 506.00K | 491.00K | 493.00K | 19.57M | |
| Total Assets | -- | 147.75M | 199.30M | 754.80M | 791.59M | |
| Current Liabilities | -- | 15.43M | 14.25M | 21.37M | 30.84M | |
| Total Debt | -- | 15.94M | 461.00K | 238.00K | 7.02M | |
| Total Liabilities | -- | 22.57M | 14.51M | 21.42M | 38.99M | |
| Retained Earnings | -- | -81.33M | -129.94M | -217.98M | -378.98M | |
| Shareholders Equity | -- | 125.18M | 184.79M | 733.38M | 752.60M | |
| Working Capital | -- | 131.78M | 179.87M | 732.84M | 728.64M | |
| Shares Outstanding | -- | 63.48M | 63.48M | 76.15M | 80.69M |
Revenue CAGR
+176.6%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+254.7%